Investigative Ophthalmology & Visual Science, Vol 26, 698-710, Copyright © 1985 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Quantitative vitreous fluorophotometry applying a mathematical model of the eye

H Lund-Andersen, B Krogsaa, M la Cour and J Larsen

A slit-lamp fluorophotometric method is presented that permits calculation of a blood-retinal barrier permeability to fluorescein (P) and a diffusion coefficient for fluorescein in the vitreous body (D). The calculations are performed by relating the time course of the free-- not protein bound--fluorescein concentration in the bloodstream with the fluorescein concentration profile in the vitreous body. The combination is performed automatically on a computer by applying a simplified mathematical model of the eye. P refers to the area of the barrier of the model eye. In a group of six normal persons, the mean P was (1.1 +/- 0.4) X 10(-7) cm/sec (mean +/- SD), while in six diabetic patients with background retinopathy and macular edema the mean P was (7.1 +/- 3.8 ) X 10(-7) cm/sec. The mean D was (7.4 +/- 3.4) X 10(-6) cm2/sec in the normal group and (9.6 +/- 2.0) X 10(-6) cm2/sec in diabetic patients, corresponding as a first approximation to free diffusion in water. Model calculations show that knowing the fluorescein concentration in the bloodstream is considerably significant for the calculation of the permeability, contributing factors up to 50%. For the low-permeation situation, subtraction of the preinjection scan contributes a factor of 50% for both permeability and diffusion coefficient. The exact placement in the vitreous body of the concentration profile, by applying a formalism that transforms slit- lamp movement to intraocular distance, contributes a factor of 20% on the diffusion coefficient. The permeability obtained with the model can be calculated as the ratio between area of vitreous and plasma fluorescein concentration curves within 20%. Active transport of fluorescein across the blood-retinal barrier in the direction of vitreous to blood does not seem to be significant within the first 2 hr after fluorescein injection.

This article has been cited by other articles:

				C. Strom, B. Sander, K. Klemp, L. P. Aiello, H. Lund-Andersen, and M. Larsen Effect of Ruboxistaurin on Blood-Retinal Barrier Permeability in Relation to Severity of Leakage in Diabetic Macular Edema Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3855 - 3858. [Abstract] [Full Text] [PDF]

				B Sander, M Larsen, C Engler, B Moldow, and H Lund-Andersen Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier Br. J. Ophthalmol., October 1, 2002; 86(10): 1139 - 1142. [Abstract] [Full Text] [PDF]

				B Sander, M Larsen, C Engler, C Strom, B Moldow, N Larsen, and H Lund-Andersen Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy Br. J. Ophthalmol., March 1, 2002; 86(3): 316 - 320. [Abstract] [Full Text] [PDF]

				B. Moldow, M. Larsen, B. Sander, and H. Lund-Andersen Passive permeability and outward active transport of fluorescein across the blood-retinal barrier in early ARM Br. J. Ophthalmol., May 1, 2001; 85(5): 592 - 597. [Abstract] [Full Text]

				B. Sander, M. Larsen, B. Moldow, and H. Lund-Andersen Diabetic Macular Edema: Passive and Active Transport of Fluorescein through the Blood-Retina Barrier Invest. Ophthalmol. Vis. Sci., February 1, 2001; 42(2): 433 - 438. [Abstract] [Full Text]

				B. Moldow, B. Sander, M. Larsen, and H. Lund-Andersen Effects of Acetazolamide on Passive and Active Transport of Fluorescein across the Normal BRB Invest. Ophthalmol. Vis. Sci., July 1, 1999; 40(8): 1770 - 1775. [Abstract] [Full Text] [PDF]